Evaluation of iStent® Inject W in mild to moderate primary open-angle glaucoma – Indian data on pseudophakic eyes
Chandrima Paul, Anujeet Paul, Nusrat FaruquePurpose:
This study aimed to evaluate the safety and efficacy of standalone bilateral iStent® Inject W implantation in pseudophakic patients with mild to moderate primary open-angle glaucoma (POAG) over 18 months.
Design:
Prospective, longitudinal study.
Methods:
Twenty-eight pseudophakic eyes with mild to moderate POAG were implanted with iStent® Inject W. Outcome measures included intraocular pressure (IOP) and change in the number of antiglaucoma medications.
Results:
The mean IOP declined from 21.14 ± 2.18 mmHg preoperatively to 15.14 ± 1.51 mmHg at 18 months postoperatively (
Conclusion:
Standalone iStent® Inject W implantation in pseudophakic patients with mild to moderate POAG results in a sustained reduction in IOP and the number of antiglaucoma medications at 18 months postoperatively.